SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF INTRAVENOUS ACYCLOVIR IN CHILDREN UNDERGOING BONE-MARROW AND LIVER-TRANSPLANT

被引：0
|
作者：
JOSHI, P
KING, S
MACLEOD, K
KLEIN, J
KOREN, G
机构：
[1] HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN PHARMACOL & TOXICOL,TORONTO,ON M5G 1X8,CANADA
[2] HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA
[3] UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA
[4] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA
[5] UNIV TORONTO,DEPT PHARM & MED,TORONTO,ON,CANADA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1995年 / 14卷 / 08期
关键词：
ACYCLOVIR; PHARMACOKINETICS; CHILD; ADOLESCENT; TRANSPLANTATION;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：717 / 719
页数：3
相关论文
共 40 条
  • [31] Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function
    Hoogkamer, JFW
    Kleinbloesem, CH
    Nokhodian, A
    Ouwerkerk, MJA
    Lankhaar, G
    Ungethum, W
    Kirch, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 51 (06) : 489 - 491
  • [32] Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor β-agonist being developed for the treatment of menopausal symptoms
    Jackson, Richard L.
    Greiwe, Jeffrey S.
    Desai, Pankaj B.
    Schwen, Richard J.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (02): : 185 - 193
  • [33] ORAL BIOAVAILABILITY OF CHF1194, AN INCLUSION COMPLEX OF PIROXICAM AND BETA-CYCLODEXTRIN, IN HEALTHY-SUBJECTS UNDER SINGLE-DOSE AND STEADY-STATE CONDITIONS
    DEROUBAIX, X
    STOCKIS, A
    ALLEMON, AM
    LEBACQ, E
    ACERBI, D
    VENTURA, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 47 (06) : 531 - 536
  • [34] Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoietic stem cell transplantation
    Kletzel, M
    Jacobsohn, D
    Duerst, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (04) : 472 - 479
  • [35] An Open-Label Study to Estimate the Effect of Steady-State Erythromycin on the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Rivaroxaban in Subjects with Renal Impairment and Normal Renal Function
    Moore, Kenneth T.
    Vaidyanathan, Seema
    Natarajan, Jaya
    Ariyawansa, Jay
    Haskell, Lloyd
    Turner, Kenneth C.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (12): : 1407 - 1420
  • [36] Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant
    S Maheshwari
    A Kassim
    R F Yeh
    J Domm
    C Calder
    M Evans
    B Manes
    K Bruce
    V Brown
    R Ho
    H Frangoul
    E Yang
    Bone Marrow Transplantation, 2014, 49 : 366 - 369
  • [37] Targeted Busulfan therapy with a steady-state concentration of 600-700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant
    Maheshwari, S.
    Kassim, A.
    Yeh, R. F.
    Domm, J.
    Calder, C.
    Evans, M.
    Manes, B.
    Bruce, K.
    Brown, V.
    Ho, R.
    Frangoul, H.
    Yang, E.
    BONE MARROW TRANSPLANTATION, 2014, 49 (03) : 366 - 369
  • [38] First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot Consortium
    Frank M. Balis
    Patrick A. Thompson
    Yael P. Mosse
    Susan M. Blaney
    Charles G. Minard
    Brenda J. Weigel
    Elizabeth Fox
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 181 - 187
  • [39] First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium
    Balis, Frank M.
    Thompson, Patrick A.
    Mosse, Yael P.
    Blaney, Susan M.
    Minard, Charles G.
    Weigel, Brenda J.
    Fox, Elizabeth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 181 - 187
  • [40] Effect of Eslicarbazepine Acetate on the Steady-State Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects During a Three-Stage, Open-Label, Multiple-Dose, Single-Period Study
    Vaz-da-Silva, Manuel
    Almeida, Luis
    Falcao, Amilcar
    Soares, Eva
    Maia, Joana
    Nunes, Teresa
    Soares-da-Silva, Patriclo
    CLINICAL THERAPEUTICS, 2010, 32 (01) : 179 - 192
1234